E. E. Mayne

ORCID: 0009-0003-5140-8495
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood Coagulation and Thrombosis Mechanisms
  • Hemophilia Treatment and Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Blood properties and coagulation
  • Cancer-related gene regulation
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Hepatitis C virus research
  • Neonatal Health and Biochemistry
  • Blood groups and transfusion
  • Hip disorders and treatments
  • Hematological disorders and diagnostics
  • Platelet Disorders and Treatments
  • Sarcoma Diagnosis and Treatment
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Kawasaki Disease and Coronary Complications
  • Healthcare Policy and Management
  • Muscle and Compartmental Disorders
  • Cardiovascular Conditions and Treatments
  • Syphilis Diagnosis and Treatment
  • Neurogenetic and Muscular Disorders Research
  • Diabetes Management and Research
  • Autoimmune and Inflammatory Disorders Research
  • Parvovirus B19 Infection Studies

Royal College of Surgeons of England
2025

Mayne Pharma (Australia)
2018

University of Ulster
1970-2000

Royal Victoria Hospital
1980-2000

Victoria Hospital
2000

Royal Victoria Hospital
1985-1998

Royal Cornwall Hospital
1996

Queen Elizabeth Hospital Birmingham
1994

Royal Victoria Eye and Ear Hospital
1969-1993

Belfast City Hospital
1970

International guidelines recommend treatment intensification combining docetaxel or androgen receptor pathway inhibitors with deprivation therapy for metastatic hormone-sensitive prostate cancer (mHSPC). However, evidence suggests underuse in many high-income countries. This study evaluates the use of English National Health Service (NHS) and explores patient hospital-level factors associated variation. All men diagnosed mHSPC England between January 2018 December 2022 were identified...

10.1016/j.ejca.2025.115335 article EN cc-by European Journal of Cancer 2025-03-03

Recent reports have suggested an association between Perthes’ disease and underlying thrombophilic or hypofibrinolytic tendency. In Northern Ireland there is a high incidence of (11.7 per 100 000 1 in 607 children) stable paediatric population. We reviewed 139 children with compared them control group 220 aged- gender-matched healthy primary schoolchildren similar racial ethnic backgrounds. There were no significant deficiencies antithrombotic factors protein C, S, antithrombin III...

10.1302/0301-620x.82b5.0820744 article EN Journal of Bone and Joint Surgery - British Volume 2000-07-01

Recent reports have suggested an association between Perthes' disease and underlying thrombophilic or hypofibrinolytic tendency. In Northern Ireland there is a high incidence of (11.7 per 100,000 1 in 607 children) stable paediatric population. We reviewed 139 children with compared them control group 220 aged- gender-matched healthy primary schoolchildren similar racial ethnic backgrounds. There were no significant deficiencies antithrombotic factors protein C, S, antithrombin III...

10.1302/0301-620x.82b5.10183 article EN Journal of Bone and Joint Surgery - British Volume 2000-07-01

The investigation of a 33 year old man with lifelong bleeding tendency is described. Defective fibrinolysis was suspected in 1968, when clinical corrected by administration aminocaproic acid. paper establishes the diagnosis as alpha 2-antiplasmin deficiency and describes its management oral tranexamic

10.1136/jcp.38.4.428 article EN Journal of Clinical Pathology 1985-04-01

Antithrombin III, factor VIII, fibrinogen and fribrinolytic activity were measured in two groups of long-standing insulin-dependent diabetic subjects (24 with proliferative retinopathy, 24 without detectable retinopathy) non-diabetic controls. Mean antithrombin III ( ± 1 SD) was 115.9 15.1), 109.8 18.1) 101.4% 12.5), respectively, the non-retinopathy control groups. Statistical significance obtained when comparing retinopathy (p < 0.001) all 48 diabetics collectively controls 0.01). VIII...

10.1159/000214367 article EN Pathophysiology of Haemostasis and Thrombosis 1980-01-01

A 28‐year‐old man who had suffered from erythropoietic protoporphyria since infancy was referred because of worsening photosensitivity. Conventional therapy with β‐carotene, terfenadine and topical sunscreens ineffective or not tolerated, he treated transfusions washed packed cells. Unexpectedly, his photosensitivity deteriorated further, whole blood protoporphyrin levels doubled developed abnormal liver function tests. This is the first report such an adverse response to transfusion for may...

10.1111/j.1365-2133.1992.tb14855.x article EN British Journal of Dermatology 1992-11-01

Thrombosis and Disseminated Intravascular Coagulation following Treatment with the Prothrombin C Complex Concentrate, DEFIX -

10.1055/s-0037-1614549 article EN Thrombosis and Haemostasis 1999-01-01

Lymphoblastic transformation of polycythaemia rubra vera is an extremely rare phenomenon. A case a 76 year old man with who developed acute lymphoblastic leukaemia (ALL) 16 years after his initial diagnosis reported. Membrane markers showed CD10 positive (common ALL) immunophenotype. To our knowledge this association has not been previously recorded. The occurrence ALL in may indicate that minority patients clonal expansion abnormal pluripotent haemopoietic stem cell responsible for the...

10.1136/jcp.47.5.471 article EN Journal of Clinical Pathology 1994-05-01

10.1016/s0368-1319(69)80027-x article EN Journal of Atherosclerosis Research 1969-05-01

We report the case of a 26‐year‐old man with haemophilia B and human immunodeficiency virus infection (HIV) who presented short history multiple dermatofibromas. He also had troublesome psoriasis for which he was receiving acitretin UVB therapy recently discontinued low‐dose daily prednisolone associated arthropathy. Multiple dermatofibromas are rare have been reported previously in association autoimmune disease, especially individuals immunosuppressive therapy. believe this to be first an...

10.1111/j.1365-2230.1995.tb01381.x article EN Clinical and Experimental Dermatology 1995-11-01

<h3>Objective</h3> To determine the short- and midterm outcome of arterial switch operation (ASO) in infants with normal abnormal coronary artery patterns. <h3>Methods</h3> A retrospective analysis was conducted experience ASO at one institution over span 20 years from 1985 through 2005. Two hundred eight consecutive ASOs were performed by same surgeon for transposition double-outlet ventricle complexes. Of 208 patterns, 159 (76%) 49 (24%) abnormal, respectively. These classified into 4...

10.1136/jcp.22.1.107 article EN Journal of Clinical Pathology 1969-01-01

Summary. To assess the viral safety of Scottish National Blood Transfusion Service (SNBTS) intermediate purity factor VIII and IX concentrates, liver function status were assessed prospectively in 13 recipients. None developed hepatitis or seroconverted to HIV HCV. This study provides additional evidence for efficacy dry heat treatment at 80°C 72 h preventing virus transmission by coagulation concentrates.

10.1111/j.1365-3148.1993.tb00065.x article EN Transfusion Medicine 1993-12-01

(1998). Familial Hemolytic Anemia Due to Hb Sabine [β91(F7)Leu←Pro] Identified BY Polymerase Chain Reaction. Hemoglobin: Vol. 22, No. 3, pp. 263-266.

10.3109/03630269809113139 article EN Hemoglobin 1998-01-01

10.1007/bf03030929 article EN Irish Journal of Medical Science (1971 -) 1977-12-01

The prevalence of the alternative alleles an unusual length polymorphism in promoter human antithrombin III (AT3) gene was determined a sample 155 unrelated individuals from Northern Irish population. 108bp L allele and 32bp S occurred at frequencies 0.21 0.79 respectively. Some homology noted between L-specific sequence region immediately downstream. Residual also evident sequences, suggesting that derived during evolution by partial deletion followed divergence. functional significance...

10.1097/00001721-199510000-00006 article EN Blood Coagulation & Fibrinolysis 1995-10-01

SUMMARY. An ion‐exchange chromatography purified factor VIII concentrate (Liberate) that had undergone a solvent—detergent viral inactivation treatment was compared with an intermediate‐purity (Z8), which terminally heated at 80°C for 72 h, in 15 haemophilia A patients blinded crossover pharmacokinetic study. Both products achieved peak level close to predicted (100IU/dl Liberate and 103IU/dl Z8) there were no significant differences the recoveries nor of any other parameters. We conclude...

10.1111/j.1365-3148.1995.tb00217.x article EN Transfusion Medicine 1995-12-01
Coming Soon ...